Dr Agostino Cilibrizzi
Senior Lecturer in Medicinal Chemistry
Biography
Agostino received his PhD degree in Chemistry and Pharmaceutical Technology from the University of Florence in 2011. He is a medicinal chemist and joined King’s College London in 2016 (Department of Imaging Chemistry & Biology, 2016-2018, and Department of Analytical, Environmental & Forensic Sciences, 2018-2019), working on a secondment as senior research scientist at Theragnostics Ltd. Prior to this, he worked at the University of Florence, University of Cambridge and Imperial College London (2013-16).
In 2019, Agostino joined the Institute of Pharmaceutical Science (KCL), to establish a Medicinal Imaging-Chemistry lab. Research in his group focuses on the synthesis (heterocycles, metal complexes/chelators, peptides) and medical applications of biologically active agents and optical probes, including the chemical analysis and the development of bioimaging techniques (biophysical assays, microscopy, NIR and PET).
Recent publications can be viewed here.
Research interests
- Medicinal Imaging Chemistry, Synthesis, Metals in Bio-Medicine & Drug Discovery
Research
Drug Discovery
The Drug Discovery Group brings together scientific expertise in a broad range of areas, from medicinal chemistry to systems biology and pharmacology.
The Multiscale Biofilm Research Hub (MBRH)
The Multiscale Biofilm Research Hub (MBRH) has been established to promote interdisciplinary interactions and focus microbial biofilm related research at King’s.
Antimicrobial resistance and biofilm therapeutics
Work involves understanding how biofilms contribute to antimicrobial resistance and the creation of new anti-biofilm therapeutics.
Project status: Ongoing
School of Cancer & Pharmaceutical Sciences: People and Culture
The School of Cancer and Pharmaceutical Science People and Culture committee is committed to fostering an equitable, diverse, and inclusive research and education environment, where everyone can thrive. We strive to support and empower members of our community, by promoting accessibility, representation, and a culture of belonging. Through advocacy, education, and meaningful action, we aim to remove barriers, address systemic inequities, and create opportunities for our whole community to contribute and succeed
Research
Drug Discovery
The Drug Discovery Group brings together scientific expertise in a broad range of areas, from medicinal chemistry to systems biology and pharmacology.
The Multiscale Biofilm Research Hub (MBRH)
The Multiscale Biofilm Research Hub (MBRH) has been established to promote interdisciplinary interactions and focus microbial biofilm related research at King’s.
Antimicrobial resistance and biofilm therapeutics
Work involves understanding how biofilms contribute to antimicrobial resistance and the creation of new anti-biofilm therapeutics.
Project status: Ongoing
School of Cancer & Pharmaceutical Sciences: People and Culture
The School of Cancer and Pharmaceutical Science People and Culture committee is committed to fostering an equitable, diverse, and inclusive research and education environment, where everyone can thrive. We strive to support and empower members of our community, by promoting accessibility, representation, and a culture of belonging. Through advocacy, education, and meaningful action, we aim to remove barriers, address systemic inequities, and create opportunities for our whole community to contribute and succeed